Literature DB >> 16774488

The challenge of effectively communicating patient safety information.

Bruce Hugman, I Ralph Edwards.   

Abstract

Rational use of drugs and patient safety are seriously compromised by a lack of good information, education and effective communication at all stages of drug development and use. From animal trials through to dispensing, there are misconceptions and opportunities for error which current methods of drug information communication do not adequately address: they do not provide those responsible for prescribing and dispensing drugs with the data and information they need to pass on complex and often changing messages to patients and the public. The incidence of adverse reactions due to the way drugs are used; the variable impact of regulatory guidelines and warnings on prescribing behaviour; drug scares and crises suggest a great gap between the ideals of the safe use of medicines and the reality in homes, clinics and hospitals around the world. To address these challenges, the authors review the several levels at which safety information is generated and communicated, and examine how, at each stage, the content and its significance, and the method of communication can be improved.

Entities:  

Mesh:

Year:  2006        PMID: 16774488     DOI: 10.1517/14740338.5.4.495

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  The good old drugs!

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  Pharmacovigilance and the null hypothesis: do we do much for public health?

Authors:  I Ralph Edwards; Ambrose Isah
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

3.  Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administration.

Authors:  Hélène Théophile; Ghada Miremont-Salamé; Philip Robinson; Nicholas Moore; Bernard Bégaud; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2011-05-20       Impact factor: 2.953

4.  Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort.

Authors:  Jonathan L Harward; Valerie B Clinard; Michael R Jiroutek; Beverly H Lingerfeldt; Andrew J Muzyk
Journal:  Prim Care Companion CNS Disord       Date:  2015-03-05

5.  Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction.

Authors:  Janine Arnott; Hannah Hesselgreaves; Anthony J Nunn; Matthew Peak; Munir Pirmohamed; Rosalind L Smyth; Mark A Turner; Bridget Young
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

6.  Effect of a workshop in rational pharmacotherapy for interns during family medicine clerkship in Samsun- Turkey.

Authors:  Mustafa Fevzi Dikici; Fusun Yaris; Fusun Artiran Igde; Fulya Yarar; Oznur Altuntas; Aysenur Alper Gurz
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.